KalVista Pharmaceuticals achieves key goals in late-stage study for hereditary angioedema therapy, demonstrating significant efficacy of sebetralstat. FDA approval filing ...
Cadence Design Systems beats analyst expectations with Q4 earnings, reporting higher-than-expected earnings per share and revenue. Despite shares falling, the ...
Australian job advertiser Seek has successfully completed its platform migration, following the approach implemented by former Commonwealth Bank CEO Ralph ...
Xponential Fitness is facing a class action lawsuit over securities fraud allegations for not disclosing franchisee financial struggles and misleading ...